Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP compliance and test procedure in accordance with national standard methods (AFNOR norm) with few deviations but no restrictions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1981
Report date:
1981

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: AFNOR T03-021
Deviations:
yes
Remarks:
The age of animals at study initiation was not reported; individual results (bodyweight, clinical signs) were not reported.
GLP compliance:
yes
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Benzyltoluene
EC Number:
248-654-8
EC Name:
Benzyltoluene
Cas Number:
27776-01-8
Molecular formula:
C14H14
IUPAC Name:
1-benzyl-2-methylbenzene; 1-benzyl-3-methylbenzene; 1-benzyl-4-methylbenzene
Test material form:
liquid
Details on test material:
- Name of test material (as cited in study report): Ugilec 101
- Physical state: colourless liquid

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River, France
- Age at study initiation: not reported
- Weight at study initiation:
Males: 189 g (mean)
Females: 157 g (mean)
- Fasting period before study: yes, animals without food from 17 to 22 hours before treatment
- Housing: 5/polycarbonate cage (40.8 cm x 33.3 cm x 15 cm)
- Diet: rodent diet ad libitum
- Water (e.g. ad libitum): ad libitum in 500- or 800-mL feeding bottle
- Acclimation period: at least 8 days


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 25
- Humidity (%): 50 +/- 20
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12


IN-LIFE DATES:
The experiments started on April 27, 1981. The sacrifice date of the animals was not reported.

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
DOSE VOLUME APPLIED:
From 1 to 10 mL/kg

Doses:
0, 2913, 3010, 3107 and 3399 mg/kg administered as 0, 3, 3.1, 3.2, 3.5 mL/kg
No. of animals per sex per dose:
5
Control animals:
yes
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: daily observation; weighing on days 0, 6 and 14
- Necropsy of survivors performed: yes
Statistics:
Derivation of the DL50 using Litchfield and Wilcoxon method.

Results and discussion

Preliminary study:
10 animals/dose level were administered 1, 5 and 10 mL/kg (equivalent to approximately 971, 4855 and 9710 mg/kg, respectively).
At 1 mL/kg, no animal died, whereas at 5 and 10 mL/kg, all animals died.
Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
3 015 mg/kg bw
95% CL:
2 962 - 3 068
Mortality:
Mortality was observed at all tested levels, from 1/10 animals at the first dose level to 10/10 animals at the highest dose level. See table 1 in the field "Remark on results including tables and figures" for further details.
Clinical signs:
other: - At the 2913 mg/kg dose level, animals exhibited a slight sedation, 2 to 3 hours after the test substance administration. On day 1, they were prostrated with mid-shut eyes. No additional symptoms were noticed from day 2 and thereafter. - At the 3010
Gross pathology:
No abnormalitites were revealed at necropsy.

Any other information on results incl. tables

Table 1 Mortality results

Treatment

Cumulated Mortality

J0 (1 h)

J0 (3 h)

J1

J4

J7

J14

Males

Vehicle

0

0

0

0

0

0

TS at 2913 mg/kg bw

0

0

1

1

1

1

TS at 3010 mg/kg bw

0

0

1

2

2

2

TS at 3107 mg/kg bw

0

0

4

5

5

5

TS at 3399 mg/kg bw

0

0

5

5

5

5

Females

Vehicle

0

0

0

0

0

0

TS at 2913 mg/kg bw

0

0

0

0

0

0

TS at 3010 mg/kg bw

0

0

3

4

4

4

TS at 3107 mg/kg bw

0

0

2

2

2

2

TS at 3399 mg/kg bw

0

0

5

5

5

5

Applicant's summary and conclusion

Interpretation of results:
Category 5 based on GHS criteria
Conclusions:
The LD50 value for the substance was calculated to be 3015 mg/kg in both sexes with a confidence interval (p<0.05) of 2962-3068 mg/kg.
Executive summary:

The possible acute oral toxicity of BENZYL TOLUENES was evaluated in Sprague-Dawley rats according to the AFNOR guideline #T03-021401 and GLP. In this study, groups of 5 Sprague-Dawley rats/sex/dose were given the substance at 0 to 3.5 mL/kg by gavage. The mortality and general behavior of the animals were observed  for a period of 14 days after the administration. The mortality rate was 10%, 60%, 70% and 100% at the dose levels of 3, 3.1, 3.2, 3.5 ml/kg, respectively. Prostration and sedation were observed after treatment. The bodyweight of the animals were not influenced by the treatment. The LD50 was found to be 3.105 ml/kg bw, equivalent to 3015 (2962-3068 mg/kg) mg/kg bw, based on the density of the substance of 0.971 mL/g.